Literature DB >> 19915887

Red blood cell membrane fluidity in the etiology of multiple sclerosis.

Gloudina M Hon1, Mogamat S Hassan, Susan J van Rensburg, Stefan Abel, Paul van Jaarsveld, Rajiv T Erasmus, Tandi Matsha.   

Abstract

Organisms adjust the order, or fluidity, of their cellular membranes in response to changes in their physiochemical environment by adjusting the lipid composition of their membranes. We investigated membrane fluidity using the phospholipid, fatty acid and cholesterol content of red blood cells (RBCs) from multiple sclerosis (MS) patients and correlated this with C-reactive protein (CRP) as well as with the severity of neurological outcome as measured by the Kurtzke Expanded Disability Status Scale (EDSS) and its Functional System Scores. The study group consisted of 31 patients with MS and 30 healthy control subjects. Phospholipids were determined using a colorimetric assay, fatty acids by gas chromatography, cholesterol by an enzymatic assay and CRP by a Beckman nephelometer. Cell membrane fluidity was calculated according to previously established formulae. RBC membrane fluidity as measured by the saturated to polyunsaturated fatty acid ratio was higher in patients than in controls (P = 0.04). The phosphatidylethanolamine saturated to polyunsaturated fatty acid ratio showed highly significant positive correlations with the EDSS and CRP < 5 microg/ml. CRP showed significant inverse correlations with the saturated nature but positive correlations with the ordered-crystalline-phase to liquid-crystalline-phase lipid ratio. In this study we show that membrane fluidity as measured by the relationship between membrane fatty acids, phospholipids and cholesterol is closely interrelated with inflammation and disease outcome in patients with MS. In conclusion, our findings suggest that the membrane lipid composition of patients with MS and, consequently, membrane fluidity are altered, which seems to be influenced by the inflammatory status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915887     DOI: 10.1007/s00232-009-9213-1

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  37 in total

Review 1.  Sphingomyelin: biophysical aspects.

Authors:  Y Barenholz; T E Thompson
Journal:  Chem Phys Lipids       Date:  1999-11       Impact factor: 3.329

Review 2.  Antioxidants and polyunsaturated fatty acids in multiple sclerosis.

Authors:  M E van Meeteren; C E Teunissen; C D Dijkstra; E A F van Tol
Journal:  Eur J Clin Nutr       Date:  2005-12       Impact factor: 4.016

3.  Hexagonal phases in phospholipids with saturated chains: phosphatidylethanolamines and phosphatidic acids.

Authors:  K Harlos; H Eibl
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

4.  Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Authors:  R T Holman; S B Johnson; E Kokmen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 5.  The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment.

Authors:  J R Hazel; E E Williams
Journal:  Prog Lipid Res       Date:  1990       Impact factor: 16.195

6.  Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis.

Authors:  Gloudina Hon; Mogamat Hassan; Susan Janse van Rensburg; Stefan Abel; De Wet Marais; Paul van Jaarsveld; Cornelius Smuts; Franclo Henning; Rajiv Erasmus; Tandi Matsha
Journal:  Br J Nutr       Date:  2009-05-19       Impact factor: 3.718

7.  Alteration of lipid-phase behavior in multiple sclerosis myelin revealed by wide-angle x-ray diffraction.

Authors:  L S Chia; J E Thompson; M A Moscarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Red blood cell fatty acids in multiple sclerosis.

Authors:  X Navarro; R Segura
Journal:  Acta Neurol Scand       Date:  1989-01       Impact factor: 3.209

9.  A comparison of composition and fluidity of multiple sclerosis and normal myelin.

Authors:  J M Boggs; M A Moscarello
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

10.  Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.

Authors:  G Giovannoni; J W Thorpe; D Kidd; B E Kendall; I F Moseley; A J Thompson; G Keir; D H Miller; M Feldmann; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

View more
  10 in total

Review 1.  Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.

Authors:  Meric A Altinoz; Emin M Ozcan; Bahri Ince; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2016-05-28       Impact factor: 3.584

2.  Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition.

Authors:  Inna Freikman; Israel Ringel; Eitan Fibach
Journal:  J Membr Biol       Date:  2011-01-23       Impact factor: 1.843

3.  Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity.

Authors:  Amelia Padilla; Magda Descorbeth; Audra L Almeyda; Kimberly Payne; Marino De Leon
Journal:  Brain Res       Date:  2010-11-23       Impact factor: 3.252

4.  The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders.

Authors:  Raymond H Thomas; Melissa M Meeking; Jennifer R Mepham; Lisa Tichenoff; Fred Possmayer; Suya Liu; Derrick F MacFabe
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

5.  A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis.

Authors:  Daniele Vergara; Michele D'Alessandro; Antonia Rizzello; Lidia De Riccardis; Paola Lunetti; Piero Del Boccio; Francesca De Robertis; Giorgio Trianni; Michele Maffia; Anna M Giudetti
Journal:  BMC Neurosci       Date:  2015-07-24       Impact factor: 3.288

6.  Increased intestinal permeability exacerbates sepsis through reduced hepatic SCD-1 activity and dysregulated iron recycling.

Authors:  Manish Kumar; Aralia Leon Coria; Steve Cornick; Björn Petri; Shyamchand Mayengbam; Humberto B Jijon; France Moreau; Jane Shearer; Kris Chadee
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

7.  General Rehabilitation Program after Knee or Hip Replacement Significantly Influences Erythrocytes Oxidative Stress Markers and Serum ST2 Levels.

Authors:  Maciej Idzik; Jakub Poloczek; Bronisława Skrzep-Poloczek; Elżbieta Chełmecka; Jerzy Jochem; Dominika Stygar
Journal:  Oxid Med Cell Longev       Date:  2022-03-30       Impact factor: 6.543

8.  Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.

Authors:  George A Jelinek; Emily J Hadgkiss; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  Int J Neurosci       Date:  2013-06-03       Impact factor: 2.292

9.  Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.

Authors:  Muhammed Emin Ozcan; Bahri Ince; Hasan Huseyin Karadeli; Asuman Gedikbasi; Talip Asil; Meric A Altinoz
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-16       Impact factor: 2.570

10.  Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.

Authors:  You-Fan Peng; Wen-Yan Cao; Qiong Zhang; Dan Chen; Zhao-Xia Zhang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.